Jounce Therapeutics, Inc. is a clinical stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long‑lasting benefits to patients. Through the use of its Translational Science Platform, Jounce first focuses on specific cell types within tumors to prioritize targets, and then identifies related biomarkers designed to match the right therapy to the right patient. Jounce’s lead product candidate, JTX-2011, is a monoclonal antibody that binds to and activates ICOS and is currently in the Phase 2 portion of the Phase 1/2 ICONIC trial. For more information, please visit www.jouncetx.com.
The Translational Sciences group at Jounce Therapeutics is seeking an individual with a background in tumor biology or immunology and experience in establishment of cell-based assays. The candidate will develop and implement 3D assays to assess molecular responses to our therapeutic molecules. You will be part of a team supporting biomarker strategies for Jounce research programs and translational efforts for new target discovery.
To apply, please visit https://careers-jouncetx.icims.com/